ARTICLE | Company News
Astion, Cipher deal
March 9, 2015 7:00 AM UTC
Astion granted Cipher exclusive, worldwide rights to develop and commercialize Dermadexin, Pruridexin and ASF-1096. Dermadexin and Pruridexin are topical barrier-repair creams containing Astion’s p...